Advertisement

Collaboration › Details
Prilenia–Leucadia: investor conference, 202006 supply service Prilenia presents at Jefferies 2020 Virtual Healthcare Conference
![]() |
Period | 2020-06-03 |
![]() |
Partner, 1st | Prilenia Therapeutics B.V. |
Group | Prilenia (Group) | |
Partner, 2nd | Jefferies LLC | |
Group | Leucadia (Group) | |
![]() |
Product | Jefferies 2020 Virtual Healthcare Conference DIGITAL |
Product 2 | pridopidine | |
![]() |
Person | Hayden, Michael R. (Prilenia Therapeutics 202006– CEO former President Global RnD + CSO at Teva) |
![]() |
Source | Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Presentation by Dr. Michael Hayden at the Jefferies Virtual Conference". |
Record changed: 2020-06-06 |
Advertisement

More documents for Prilenia (Group)
- [1] Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Prilenia Therapeutics Raises $62.5m to Fund Late Stage Trials in HD and ALS". Naarden & Herzliya....
- [2] Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Presentation by Dr. Michael Hayden at the Jefferies Virtual Conference"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top